The applicability of powder X-ray diffraction to the quantification of drug substance polymorphs using a model organic system
Source abstract
Abstract
With a new emphasis on the control of polymorphism in pharmaceutical production, the need for methods to quantify polymorphic forms has arisen. Techniques using X-ray powder diffraction are increasingly being used to characterize the phases of drug substances that exist in multiple crystal forms. Current methods to identify the polymorphic phases in a drug substance include microscopy, infrared spectroscopy, thermal analysis (DSC/TGA), solid state NMR, and X-ray powder diffraction. Of the aforementioned techniques, X-ray powder diffraction provides the most effective approach to identify and quantify the different crystal phases of a pharmaceutical compound. This work is intended as a guide to the characterization and quantification of an organic crystalline system using X-ray diffraction. The approaches suggested are intended to provide assistance not only from an in-process pharmaceutical manufacturing standpoint, but also for routine quality assurance screening of polymorphic drug substances.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: X-ray Diffraction in Crystallography · Crystallization and Solubility Studies · Analytical Chemistry and Chromatography
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (11)
Show source-provided references
1. Lachman · 1976 · 467
2. Ludlam · Adv. X-ray Anal. · 1991 · 29 · 625
3. Klug · 1974 · 486
4. 10.1002/jps.260064080510.1002/jps.2600640805 ↗
5. 10.1111/j.2042-7158.1974.tb09324.x10.1111/j.2042-7158.1974.tb09324.x ↗
6. Byrn · 1982 · 3
7. 10.1002/jps.260056071210.1002/jps.2600560712 ↗
8. 10.1002/jps.260058080210.1002/jps.2600580802 ↗
9. 10.1107/S056774088100249510.1107/S0567740881002495 ↗
10. 10.1017/S088571560001560810.1017/S0885715600015608 ↗
11. 10.3109/0363904910905729810.3109/03639049109057298 ↗